Gate News message, April 16 — Novo Nordisk, the world’s leading manufacturer of diabetes and obesity treatment medications, announced on April 14 a strategic partnership with OpenAI to accelerate drug development and integrate AI across manufacturing, supply chain, and corporate operations.
The collaboration focuses on analyzing complex datasets to identify promising drug candidates and shortening the timeline from pre-clinical stages to market launch. OpenAI’s latest AI models will be applied to strengthen Novo Nordisk’s next-generation drug pipeline, including treatments like Ozempic and Wegovy. OpenAI will also provide employee training programs to enhance AI capabilities across the organization. Pilot programs will begin in research and development, manufacturing, and commercial operations, with full company-wide integration planned by end of 2026. The financial terms were not disclosed.
Novo Nordisk CEO Mike Doustdar emphasized the partnership aims at human augmentation rather than workforce reduction. The collaboration reflects accelerating partnerships between Big Pharma and Big Tech, with companies like Eli Lilly and AstraZeneca also strengthening ties with AI firms. Experts anticipate Novo Nordisk’s extensive clinical data combined with OpenAI’s large language models could expand research beyond obesity and diabetes to cardiovascular and rare diseases, potentially revolutionizing the pharmaceutical industry’s innovation pace.
Disclaimer: The information on this page may come from third parties and does not represent the views or opinions of Gate. The content displayed on this page is for reference only and does not constitute any financial, investment, or legal advice. Gate does not guarantee the accuracy or completeness of the information and shall not be liable for any losses arising from the use of this information. Virtual asset investments carry high risks and are subject to significant price volatility. You may lose all of your invested principal. Please fully understand the relevant risks and make prudent decisions based on your own financial situation and risk tolerance. For details, please refer to
Disclaimer.
Related Articles
Arthur Hayes posts: Before the Federal Reserve injects liquidity, it’s hard to see a significant upward move in Bitcoin
Arthur Hayes analyzed the Bitcoin price trend on April 15 on his personal blog. He said that before the Federal Reserve injects liquidity, Bitcoin is unlikely to surge significantly, and he set a short-term target of $80,000 to $90,000. He holds unleveraged long positions, is optimistic about crypto, and cites data analysis on three major geopolitical scenarios.
MarketWhisper7m ago
Aave Labs launches Aave Checkpoint, using human review to mitigate DAO governance risks
Aave Labs released the Aave Checkpoint on April 15, combining AI-based automated analysis and mandatory manual review, requiring at least two reviewers to verify governance proposals. The system has been operating since March 2026 and covers DeFi risks such as oracle manipulation. At the same time, Aave V4 introduces a reinvestment module that dynamically allocates idle liquidity while maintaining immediate fund liquidity.
MarketWhisper7m ago
Anthropic restricts the public release of the Mythos model on the grounds of national security
Anthropic is limiting the public release of its Claude Mythos AI model because tests showed it has the ability to carry out automated cyberattacks, posing a risk to national security. Organizations participating in the “Wings of Glass” program include Amazon, Apple, Cisco, and others; Anthropic is providing $100 million in funding. The U.S. Treasury Department and the IMF have also raised concerns about the risks of Mythos, emphasizing that defensive measures are insufficient.
MarketWhisper7m ago
TSMC Q1 Revenue Beats Expectations at $11.34B, Driven by AI Chip Demand; Q2 Outlook Positive
Taiwan's TSMC reported Q1 2026 revenue of $11.34 billion, driven by high HPC chip demand, surpassing expectations. Operating margin rose to 58.1%. Advanced-nodes made up significant revenue, with strong AI orders. Q2 guidance also exceeds estimates.
GateNews17m ago
NVIDIA CEO Jensen Huang’s Latest Interview: Can NVIDIA’s Moat Continue to Hold? (Part 1)
NVIDIA CEO Jensen Huang said in an interview that AI competition is not just a single model or chip, but involves a complex, multi-layered ecosystem. He believes NVIDIA is responsible for a key part of the “conversion from electrons to tokens,” which is difficult to commoditize. In response to market doubts, Huang said NVIDIA’s supply-chain advantage and investments in upstream areas will continue to drive growth. He believes AI will foster the development of tool-based software companies, rather than replace them. As for industry bottlenecks, he thinks most can be resolved within two to three years, with energy policy being the only long-term challenge.
ChainNewsAbmedia24m ago
OpenAI Shifts ChatGPT Ad Model to CPC, Targeting $2.4-2.5B Ad Revenue in 2026
OpenAI is shifting ChatGPT's advertising model from cost-per-impression to cost-per-click amid financial pressures. Despite 900 million weekly users, only 5% subscribe, leading to losses. The change aims to target ad revenue growth while maintaining user trust.
GateNews34m ago
